ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
“Does Nanomedicine Have a Delivery Problem?” (C&EN, June 20, page 16), which surveyed the state of cancer nanomedicines’ delivery efficiencies, piqued readers’ interest.
▸ cenm.ag/nanodelivery
Short answer [to the story’s headline]: YES! This is the holy grail pursuit of our time.
Carolyn Bertozzi (@CarolynBertozzi) via Twitter
Great article. Critical reviews that highlight shortcomings and challenges in a field instead of only the advances are the most educational in my opinion.
David McLeod via Facebook
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X